Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 10:00 AM ET

Date/Time Source News Release
05/29/2025 08:00 AM EDT GlobeNewswire CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
05/19/2025 08:00 AM EDT GlobeNewswire CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma
05/12/2025 06:50 AM EDT GlobeNewswire CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
05/12/2025 06:15 AM EDT GlobeNewswire CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)
05/12/2025 06:15 AM EDT GlobeNewswire CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update
05/05/2025 08:00 AM EDT GlobeNewswire CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025
04/28/2025 04:00 PM EDT GlobeNewswire CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting
03/06/2025 04:10 PM EST GlobeNewswire CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update
03/05/2025 08:00 AM EST GlobeNewswire CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference
02/27/2025 08:00 AM EST GlobeNewswire CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
Page

Additional News

As of June 7, 2025 • 10:00 AM ET

Date/Time Source News Release
05/15/2025 10:06 AM EDT SeekingAlpha CytomX upgraded at H.C. Wainwright on trial data for cancer drug
05/13/2025 10:34 AM EDT SeekingAlpha CytomX Therapeutics: Doubling Overnight On Phase 1 Data... Still Bullish?
05/12/2025 02:40 PM EDT SeekingAlpha CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)
05/12/2025 10:14 AM EDT 24/7 Market News 5 Hot Trades with News GRYP, ARLSF, CTMX, FRGT, and CAN
05/12/2025 07:25 AM EDT Zacks CytomX Therapeutics (CTMX) Beats Q1 Earnings and Revenue Estimates
05/12/2025 07:11 AM EDT SeekingAlpha CytomX Therapeutics jumps 54% after Q1 beat, prices $100M offering
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 06:26 AM EDT SeekingAlpha CytomX GAAP EPS of $0.27 beats by $0.09, revenue of $50.92M beats by $15.5M
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - CytomX Therapeutics Inc.
05/09/2025 05:40 PM EDT Zacks SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Misses Revenue Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.